Related Experiment Video
Updated: Dec 12, 2025

14:27
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
16.0K
White Matter Hyperintensities Related to Parkinson's Disease Executive Function
Patricia Linortner1, Colin McDaniel1, Marian Shahid1
1Department of Neurology and Neurological Sciences Stanford University Palo Alto California USA.
Movement Disorders Clinical Practice
|August 11, 2020
Summary
Vascular disease, seen as white matter hyperintensities (WMH), is linked to executive dysfunction in Parkinson's disease (PD). Addressing vascular issues may help improve cognitive function in some PD patients.
Area of Science:
- Neuroscience
- Neurology
- Radiology
Background:
- Parkinson's disease (PD) is associated with multidomain cognitive impairments.
- The specific pathologies driving domain-specific cognitive dysfunction in PD remain unclear.
Purpose of the Study:
- To investigate the contribution of vascular copathology, specifically white matter hyperintensities (WMH) severity and location via MRI, to domain-specific cognitive impairment in Parkinson's disease.
Main Methods:
- Studied 85 PD patients and 18 controls, assessing WMH severity using the Fazekas scale.
- Classified PD patients into PD with WMH (PD+WMH) and without WMH (PD-WMH) groups.
- Conducted cognitive testing (global, executive, visuospatial, memory, language) and generated WMH probability maps.
Main Results:
- The PD+WMH group exhibited poorer global and executive cognitive performance compared to the PD-WMH group.
- Specific cognitive deficits in PD+WMH included lower scores on MoCA, Stroop, SDMT, and Digit Span.
- WMH probability maps indicated lesion locations associated with specific cognitive deficits, such as the corticospinal tract for executive functions.
Conclusions:
- WMH severity correlates with executive dysfunction in PD, affecting attention, working memory, and processing speed.
- Disruption of white matter tracts near vascular lesions likely contributes to these cognitive impairments.
- Early vascular disease management may alleviate executive dysfunction in a subset of PD patients.
Related Concept Videos
Parkinson's Disease: Overview
1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Neural Regulation
42.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.7K
Parkinson's Disease: Treatment
824
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
824
Attention-Deficit/Hyperactivity Disorder
609
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
609
Alzheimer's Disease: Overview
1.4K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.4K

